Schizophrenia

>

The HCPLive schizophrenia page is a resource for medical news and expert insights on the mental disorder. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for schizophrenia, and more.

Latest News

Study Identifies Homelessness as a Predictor Against Clozapine Use
Study Identifies Homelessness as a Predictor Against Clozapine Use

November 22nd 2024

A study identified homelessness and minority status as factors that impact clozapine prescription patterns.

Hallucinogen-Related ER Visit Linked to Increased Schizophrenia Risk
Hallucinogen-Related ER Visit Linked to Increased Schizophrenia Risk

November 14th 2024

Emraclidine Fails to Significantly Reduce Schizophrenia Symptoms in Phase 2 EMPOWER Trials
Emraclidine Fails to Significantly Reduce Schizophrenia Symptoms in Phase 2 EMPOWER Trials

November 11th 2024

Phase 3 Data Shows Lumateperone Delays Schizophrenia Relapse Longer Than Placebo
Phase 3 Data Shows Lumateperone Delays Schizophrenia Relapse Longer Than Placebo

November 6th 2024

Phase 3 Data Shows TEV-‘749 Injection Improves Social Function in Schizophrenia
Phase 3 Data Shows TEV-‘749 Injection Improves Social Function in Schizophrenia

November 6th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.